National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, 20892, United States
NCT Number: NCT00001356
This study will determine what growth factors are involved in promoting and inhibiting mastocytosis-an abnormal increase of mast cells in one or more organ systems. Mast cells release chemicals that can cause itching, blisters, flushing, bone pain, and abdominal pain. Little is known about the disease and there is no cure. Steroids and antihistamines can help reduce some symptoms.
Patients from birth to 80 years of age with increased mast cells in at least one organ system may be eligible for this 3-year study. Family members may also be enrolled for genetic testing.
Patients will be evaluated yearly at the NIH Clinical Center with the following tests and procedures:
* Medical history and physical examination. * Blood samples. * Laboratory blood tests, as medically indicated. * Bone marrow aspiration and biopsy - For the bone marrow aspiration and biopsy, the back hipbone is punctured with a sterile needle. Five milliliters (1 teaspoon) of marrow is withdrawn through a syringe and a 1/2-inch piece of tissue is extracted with a special needle.
The blood and bone marrow samples will be used for clinical care and for research to determine if mastocytosis is due to mast cell growth factors or genetic changes.
Patients who require further evaluation and tests will have recommendations made to their primary physician. Any patient who requires immediate treatment will be admitted to the hospital. Standard medical treatment may include antihistamines for itching; steroids for severe abdominal symptoms such as cramping, diarrhea, and evidence of increased mast cells determined by an upper GI study; and adrenaline for anaphylactic shock. Patients who do not respond to conventional treatment may be offered participation in an experimental therapy study.
Participating family members will have a medical history and a blood sample drawn to look for genetic abnormalities.
Looking for future studies?
Notify MeAll sexes
Observational
Bethesda, Maryland, 20892, United States
This protocol is designed to examine those growth potentiating and inhibiting factors which regulate mast cell number in patients with mastocytosis, and to explore the molecular basis of the disease process in hopes of improving therapy. Patients entered into the study are seen initially and may elect to be reevaluated yearly. The majority of patients to be entered into this protocol are currently followed at NIH on other protocols. Medical workup and treatment are in accordance with standard medical practice. The protocol is for 3 years, to be extended as facilities, faculty, and patients permit.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Subjects include children and adults from birth to 80 years of age.
Participants must have histologic evidence of an increased mast cell number in at least one organ system.
Must be willing to be seen at the NIH according to protocol guidelines.
Routine medical care must be available through their referral physician.
Patients with mastocytosis now followed at the NIH on protocol 88-I-0190 will be continued on this study.
National Institute of Allergy and Infectious Diseases (NIAID)
Nih
Culture and Characteristics of Mastocytosis Mast Cells
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01384513
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00255346
Acute Myeloid Leukemia, Agnogenic Myeloid Metaplasia
Houston, Texas, United States
View Trial DetailsNCT00001756
Healthy Volunteer, Immune System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT00038675
Bone Marrow Diseases, Bone Marrow Neoplasms
Houston, Texas, United States
View Trial Details